{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:53481793",
      "entity_text" : "endotoxin",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UA-BP-GGP-00007",
      "entity_text" : "antigen",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Here we report the therapeutic potential of a novel formula of tacrolimus eyedrop i.e., 0.03% tacrolimus dissolved in F4H5, in mouse models of uveitis, including the endotoxin induced uveitis (EIU), a model of human anterior uveitis, and retinal antigen peptide induced experimental autoimmune uveoretinitis (EAU), a model of human posterior uveitis.",
  "reading_complete" : "2020-07-28T12:06:27Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T12:03:00Z",
  "trigger" : "induced",
  "evidence" : [ "endotoxin induced uveitis (EIU), a model of human anterior uveitis, and retinal antigen" ],
  "pmc_id" : "5759177",
  "score" : 0
}